I think a couple of things could be done. Continued support and growth of basic biomedical discovery research, I think, is important. As was pointed out, you never know where it's going to end up, but it's improving knowledge, and that has resulted in development of antibiotics and a number of other approaches that have saved health care dollars.
The other is that there could be a focus on repurposing existing drugs. I think that the development of brand new drugs takes a long time and has to go through a number of hurdles. If we used drugs that are already very well characterized, but used them in new ways and new approaches that are scientifically validated, I think that's a way of shortening that pipeline.